Results 301 to 308 of about 73,649 (308)

<p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>

OncoTargets and Therapy, 2019
Francesco Perri, F Caponigro, F Ionna
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Cheng-Long Huang, Wen-Fei Li   +2 more
exaly  

Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)

Radiotherapy and Oncology, 2006
Stewart Y Tung, Benny Zee, Anne W M Lee
exaly  

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Annals of Oncology, 2013
C Xue
exaly  

Genetic and epigenetic changes in nasopharyngeal carcinoma

Seminars in Cancer Biology, 2002
Kwok-Wai Lo, Dolly P Huang
exaly  

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma

Radiotherapy and Oncology, 2012
Gang Peng, Kun-Yu Yang
exaly  

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Annals of Oncology, 2002
exaly  

Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape

Ca-A Cancer Journal for Clinicians
exaly